Temporal artery biopsy as a means of diagnosing giant cell arteritis: Is there over-utilization?

American Surgeon

Volumn 77, Issue 9, 2011, Pages 1158-1160

  Goslin, Brent J ^a,b   Chung, Mathew H ^a,b,c,d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c SPECTRUM HEALTH   (United States)

^d Michigan Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; BLOOD VESSEL BIOPSY; CLINICAL ARTICLE; COMMUNITY HOSPITAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; MALE; PATIENT CARE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; TEMPORAL ARTERY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TEMPORAL ARTERIES;

EID: 80052068583     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hunder G, Bloch D, Michel B, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1125.
2. Brauner D, Sorensen L, Ellman M. Rheumatologic Diseases. Geriatric Medicine: An Evidence Based Approach, 4th Ed. New York: Spring-Verlag, Inc., 2003.
3. Berger C, Wolbers M, Meyer P, et al. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology 2009;48:258-61.
4. Hedges TR III, Gieger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 1983; 101:1251-4. (Pubitemid 13030945)
5. Mahr A, Saba M, Kambouchner M. Temporal artery biopsy for diagnosing giant cell arteritis: The longer, the better? Ann Rheum Dis 2006;65:826-8. (Pubitemid 43799187)
6. Niederkohr R, Levin L. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci 2007;48:675-80. (Pubitemid 351260700)
7. Narvaez J, Bernad B, Roig-Vilaseca D, et al. Incidence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 2007;37:13-9. (Pubitemid 47087885)
8. Comment. The value of temporal artery biopsy specimen length in the diagnosis of giant cell arteritis. J Rheum 2006;33: 1279-82.
9. Davis C, Frost B, Eshan O, et al. Temporal artery biopsy. . .who needs one? Postgrad Med J 2006;82:476-8. (Pubitemid 44076312)
10. Allison M, Gallagher P. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 1984;43:416-7. (Pubitemid 14117914)
11. Moutray T, Williams M, Best J. Suspected giant cell arteritis: A study of referrals for temporal artery biopsy. Can J Ophthalmol 2008;43:445-8.
12. Taylor-Gjevre R, Vo M, Shukla D, et al. Temporal artery biopsy for giant cell arteritis. J Rheum 2005;32:1279-82. (Pubitemid 40995383)
13. Sharma N, Ooi J, McGarity B, et al. The length of superficial temporal artery biopsies. ANZ J Surg 2007;77:437-9. (Pubitemid 46733803)
14. Gordon LK, Levin LA. Visual loss in giant cell arteritis. JAMA 1998;280:385-6. (Pubitemid 28503227)
15. Chong E, Robertson A. Is temporal artery biopsy a worth-while procedure? ANZ J Surg 2005;75:388-91. (Pubitemid 40896897)
16. Lenton J, Donnelly R, Nash J. Does temporal artery biopsy influence the management of temporal arteritis. QJM: An International Journal of Medicine 2006;99:33-6. (Pubitemid 43124969)